Organogenesis Holdings Inc.
ORGO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $421,354 | $536,736 | $349,889 | $1,185,779 |
| - Cash | $135,571 | $104,338 | $102,478 | $113,929 |
| + Debt | $43,312 | $119,351 | $123,791 | $132,303 |
| Enterprise Value | $329,095 | $551,749 | $371,202 | $1,204,153 |
| Revenue | $482,043 | $433,140 | $450,893 | $467,359 |
| % Growth | 11.3% | -3.9% | -3.5% | – |
| Gross Profit | $366,302 | $326,659 | $345,874 | $353,160 |
| % Margin | 76% | 75.4% | 76.7% | 75.6% |
| EBITDA | $15,763 | $36,031 | $40,322 | $86,998 |
| % Margin | 3.3% | 8.3% | 8.9% | 18.6% |
| Net Income | $861 | $4,945 | $15,532 | $94,202 |
| % Margin | 0.2% | 1.1% | 3.4% | 20.2% |
| EPS Diluted | 0.007 | 0.037 | 0.12 | 0.7 |
| % Growth | -82.6% | -68.9% | -82.9% | – |
| Operating Cash Flow | $14,208 | $30,917 | $24,859 | $61,978 |
| Capital Expenditures | -$10,032 | -$24,364 | -$33,898 | -$31,220 |
| Free Cash Flow | $4,176 | $6,553 | -$9,039 | $30,758 |